Literature DB >> 18620043

Statistical methods for estimating the probability of spontaneous abortion in observational studies--analyzing pregnancies exposed to coumarin derivatives.

Reinhard Meister1, Christof Schaefer.   

Abstract

BACKGROUND: Spontaneous abortion rates are of general interest when investigating pregnancy outcome. In most studies observations are left truncated as pregnant women enter with a delay of several weeks after conception. Apart from spontaneous abortion pregnancy may end in induced abortion or live birth. These outcomes are considered as competing events (risks). Although statistical methods for handling this setting are available since more than 10 years, studies on pregnancy outcome after drug exposure usually report crude rates of spontaneous abortions, ignoring left truncation and competing risks.
METHODS: The authors propose simple methods which remove bias inherent to crude rates. The probability of spontaneous abortion is estimated using an event-history based approach for the subdistribution of competing risks that handles left truncation appropriately. Variance estimation enables the construction of approximate confidence intervals and of a simple test-statistic for comparing rates between different cohorts. The proposed methods are applied to a comparative prospective study on the association of spontaneous abortion and exposure to coumarin derivatives.
RESULTS: The naive analysis using crude rates gives substantially different results than those based on the proposed methods, with up to a twofold change. Correctly incorporating left truncation into the analysis may increase the variance of the estimators, relative to an ideal sample where all pregnancies are followed from the time of conception. The consequences of such truncation for study design are discussed.
CONCLUSION: Combining corrections for left truncation and competing risks offers a powerful method for analyzing miscarriage risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620043     DOI: 10.1016/j.reprotox.2008.06.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  21 in total

1.  Bias due to left truncation and left censoring in longitudinal studies of developmental and disease processes.

Authors:  Kevin C Cain; Siobán D Harlow; Roderick J Little; Bin Nan; Matheos Yosef; John R Taffe; Michael R Elliott
Journal:  Am J Epidemiol       Date:  2011-03-21       Impact factor: 4.897

2.  Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.

Authors:  Stephanie Padberg; Evelin Wacker; Reinhard Meister; Mary Panse; Corinna Weber-Schoendorfer; Marc Oppermann; Christof Schaefer
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

3.  A nonparametric maximum likelihood approach for survival data with observed cured subjects, left truncation and right-censoring.

Authors:  Jue Hou; Christina D Chambers; Ronghui Xu
Journal:  Lifetime Data Anal       Date:  2017-12-13       Impact factor: 1.588

4.  Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study.

Authors:  Maria Hoeltzenbein; Tatjana Tissen-Diabaté; Anne-Katrin Fietz; Sandra Zinke; Angela Kayser; Reinhard Meister; Corinna Weber-Schoendorfer; Christof Schaefer
Journal:  Clin Res Cardiol       Date:  2018-03-24       Impact factor: 5.460

5.  Drug safety in pregnancy: the German Embryotox institute.

Authors:  Katarina Dathe; Christof Schaefer
Journal:  Eur J Clin Pharmacol       Date:  2017-10-24       Impact factor: 2.953

6.  Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort study.

Authors:  Wayan Philipps; Anne-Katrin Fietz; Katja Meixner; Tobias Bluhmki; Reinhard Meister; Christof Schaefer; Stephanie Padberg
Journal:  Infection       Date:  2019-07-13       Impact factor: 3.553

7.  Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.

Authors:  Corinna Weber-Schoendorfer; Marc Oppermann; Evelin Wacker; Nathalie Bernard; Delphine Beghin; Benedikte Cuppers-Maarschalkerweerd; Jonathan L Richardson; Laura E Rothuizen; Alessandra Pistelli; Heli Malm; Georgios Eleftheriou; Debra Kennedy; Mine Kadioglu Duman; Reinhard Meister; Christof Schaefer
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

8.  Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.

Authors:  M Hoeltzenbein; E Beck; K Meixner; C Schaefer; R Kreutz
Journal:  Clin Res Cardiol       Date:  2015-07-21       Impact factor: 5.460

9.  Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.

Authors:  Alice Panchaud; Valentin Rousson; Thierry Vial; Nathalie Bernard; David Baud; Emmanuelle Amar; Marco De Santis; Alessandra Pistelli; Anne Dautriche; Frederique Beau-Salinas; Matteo Cassina; Hannah Dunstan; Anneke Passier; Yusuf Cem Kaplan; Mine Kadioglu Duman; Eva Maňáková; Georgios Eleftheriou; Gil Klinger; Ursula Winterfeld; Laura E Rothuizen; Thierry Buclin; Chantal Csajka; Sonia Hernandez-Diaz
Journal:  Br J Clin Pharmacol       Date:  2018-01-14       Impact factor: 4.335

10.  Accuracy loss due to selection bias in cohort studies with left truncation.

Authors:  Enrique F Schisterman; Stephen R Cole; Aijun Ye; Robert W Platt
Journal:  Paediatr Perinat Epidemiol       Date:  2013-09       Impact factor: 3.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.